Showing results (111-120 of 219) with videos related to

Sort By:
Pageof 22
Scientific Reports|March 4, 2021
PET/CT in therapy control of infective native aortic aneurysmsLars Husmann, Martin W Huellner, Nadia Eberhard, et al.
AIDS (London, England)|November 2, 2005
Dose-dependent influence of didanosine on immune recovery in HIV-infected patients treated with tenofovirUrs Karrer, Bruno Ledergerber, Hansjakob Furrer, et al.
Archives of Internal Medicine|October 15, 2003
CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort StudyGilbert R Kaufmann, Luc Perrin, Guiseppe Pantaleo, et al.
AIDS (London, England)|August 28, 2007
Short-term clinical disease progression in HIV-1-positive patients taking combination antiretroviral therapy: the EuroSIDA risk-scoreAmanda Mocroft, Bruno Ledergerber, Kai Zilmer, et al.
Antiviral Therapy|April 28, 2006
Eligibility for and outcome of hepatitis C treatment of HIV-coinfected individuals in clinical practice: the Swiss HIV cohort studyAnnelies S Zinkernagel, Viktor von Wyl, Bruno Ledergerber, et al.
Scientific Reports|July 6, 2022
Prediction of benzimidazole therapy duration with PET/CT in inoperable patients with alveolar echinococcosisLars Husmann, Hannes Gruenig, Caecilia S Reiner, et al.
Open Forum Infectious Diseases|October 14, 2017
Associations Between Antiretroviral Treatment and Avascular Bone Necrosis: The Swiss HIV Cohort StudyCornelia Bayard, Bruno Ledergerber, Markus Flepp, et al.
The Journal of Infectious Diseases|February 4, 2011
Association of pharmacogenetic markers with premature discontinuation of first-line anti-HIV therapy: an observational cohort studyRubin Lubomirov, Sara Colombo, Julia di Iulio, et al.
Pageof 22